Upexi Raises $23 Million in Private Placement of Shares and Warrants

Reuters
Nov 26
Upexi Raises $23 Million in Private Placement of Shares and Warrants

Upexi Inc. has announced the pricing of a private placement offering of up to $23 million in common stock and warrants, sold to a single institutional investor. The offering includes 3,289,474 shares of common stock and warrants to purchase the same number of shares at a combined price of $3.04 per share, which is above the current at-the-market price. The warrants are immediately exercisable at $4.00 per share and will expire 48 months from issuance. Upexi expects to receive $10 million upfront, with the potential for an additional $13 million if all warrants are exercised. The securities are being issued in a transaction exempt from SEC registration, with plans to file a resale registration statement following the closing, which is expected on or around December 1, 2025. Proceeds will be used for working capital, general corporate purposes, and the company's Solana-focused investment strategy. A.G.P./Alliance Global Partners is serving as the sole placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Upexi Inc. published the original content used to generate this news brief on November 26, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10